Navigation Links
PharmAthene Reports Third Quarter 2013 Financial And Operational Results
Date:11/7/2013

ANNAPOLIS, Md., Nov. 7, 2013 /PRNewswire/ -- 

Recent Highlights

  • On track to commence SparVax® Phase 2 clinical trial
  • Presented new SparVax® anthrax vaccine data at the 2013 Bacillus-ACT International Conference and the 53rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
  • Advanced proposed merger with Theraclone Sciences; filed amended Form S-4 registration statement and set date for special stockholders meeting
  • PharmAthene, Inc. (NYSE MKT: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, today reported its financial and operational results for the third quarter ended September 30, 2013.

    "Progress in our next generation SparVax® anthrax vaccine program continued at a steady pace in the third quarter," commented Eric I. Richman, President and Chief Executive Officer.  "PharmAthene scientists presented new analytical and non-clinical animal data for SparVax® at two important medical meetings. The data provided further confirmation of the immunogenicity and efficacy of SparVax® and demonstrated our progress in developing a newer, more robust functional assay for anthrax vaccine development.  We are also pleased to report that we are on track to initiate the planned Phase 2 clinical trial of SparVax®, which we anticipate will begin by the end of the year."

    Mr. Richman continued, "Most importantly, during the third quarter we announced our proposed merger with Theraclone Sciences, a privately-held company with impressive monoclonal antibody (mAb) discovery and development capabilities. Following the completion of the merger, the new company will feature vaccine and human monoclonal antibody expertise with a focus on infectious diseases and oncology and a robust pipeline with four clinical-stage and multip
    '/>"/>

    SOURCE PharmAthene, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference
    2. PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets
    3. PharmAthene Reports First Quarter 2013 Financial And Operational Results
    4. New Data Show PharmAthenes Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents
    5. SIGA Technologies Files Notice of Appeal in PharmAthene Litigation
    6. Pharmacyclics Reports Third Quarter 2013 Results
    7. CareFusion Reports First Quarter Fiscal 2014 Results
    8. Sequenom, Inc. Reports Financial Results For The Third Quarter Of 2013
    9. Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2013 Financial Results
    10. Nektar Therapeutics Reports Financial Results for the Third Quarter of 2013
    11. ANI Pharmaceuticals Reports Net Revenues of $7.8 million, adjusted Non-GAAP EBITDA of $1.7 Million, and EPS of $0.13 for the Third Quarter Ended September 30, 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/1/2015)... DUBAI , UAE, June 2, 2015 /PRNewswire/ ... to create the first, mainstream reporting standard for ... Principles. The next big step in CSR: The Islamic ... Launched only last month, the Islamic ... from across the Islamic world.  The latest members ...
    (Date:6/1/2015)... -- LaunchPad Medical, LLC announced today that it has ... Corporation,s (NYSE: SYK ) bone adhesive technology, ... Under the terms of the agreement, LaunchPad has ... this technology which is covered by four issued ... from multiple pre-clinical animal studies.  LaunchPad will seek ...
    (Date:6/1/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) ... focus on Omega-3 therapies for cardiovascular disease (CVD) ... financial results for the three months ended March ... in Canadian dollars unless otherwise stated. ... despite its limited financial resources," stated Mr. ...
    Breaking Medicine Technology:Call for Partners: Islamic CSR 2LaunchPad Medical Executes Definitive License Agreement with Stryker for Novel Bone Adhesive Technology 2Pivotal Therapeutics Announces First Quarter Financial Results 2Pivotal Therapeutics Announces First Quarter Financial Results 3Pivotal Therapeutics Announces First Quarter Financial Results 4Pivotal Therapeutics Announces First Quarter Financial Results 5
    ... 2010 Sequenom, Inc. (Nasdaq: SQNM ) ... Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized ... study is designed to evaluate the clinical performance of ... detection of an overabundance in maternal blood of chromosome ...
    ... 22, 2010 Renal Advantage and Liberty Dialysis, which last ... of dialysis services in the U.S., today announced that they ... were not disclosed – was completed on December 17, 2010. ... patients in 260 locations in 32 states. "The ...
    Cached Medicine Technology:Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 2Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 3Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test 4Renal Advantage and Liberty Dialysis Deal Completed 2Renal Advantage and Liberty Dialysis Deal Completed 3
    (Date:6/1/2015)... The National Association of Professional ... a 2015-2016 inductee into its VIP Woman of the ... for leadership in business. NAPW is the nation’s leading ... 700,000 members and over 200 operating Local Chapters. , ... said NAPW President Star Jones. “Job satisfaction is essential ...
    (Date:6/1/2015)... NY (PRWEB) June 02, 2015 ... Lourinda Willey as a 2015-2016 inductee into ... is recognized with this prestigious distinction for leadership in ... nation’s leading networking organization exclusively for professional women, boasting ... Chapters. , "I’m pleased to present Lourinda with this ...
    (Date:6/1/2015)... The National Association of Professional Women ... (C), First Sergeant A Co., 15BSB , as a ... Circle. She is recognized with this prestigious distinction for ... networking organization exclusively for professional women, boasting more than ... “I'm pleased to recognize Sergeant Cornett with this important ...
    (Date:6/1/2015)... 2015 The federal court overseeing hundreds ... the Case Management Order governing case selection for bellwether ... Amended Order which was issued in the U.S. District ... directs the parties to submit a Proposed Case Management ... outlines parameters and the process for selecting AbbVie-only plaintiffs ...
    (Date:6/1/2015)... (PRWEB) June 01, 2015 Linda Kincaid, age ... had an irregular heartbeat. At first she thought it was ... out it was much more than that. After going to ... Linda admitted she felt afraid about what might happen to ... million Americans are diagnosed with valve disease each year. Valve ...
    Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3
    ... NEW YORK, Sept. 9 Twitter users can now contribute to the ... ), the joint venture between Dow Jones (Nasdaq: NWS ) ... Twitterverse to send in their best 3-word ideas on how to fix ... In the FiLife "Fix Healthcare" Twitter contest, contestants Tweet their ...
    ... , , NASHVILLE, ... NUTRO(R) ULTRA(TM) food for dogs recipe featuring superfoods for a unique ... NUTRO(R) ULTRA(TM) food for dogs is at the forefront of the ... the dog food marketplace with the ULTRASSENTIAL(TM) Superfood Blend, a proprietary ...
    ... , PARKER, Colo., Sept. 9 According to the ... suffer from Post Traumatic Stress Disorder, or PTSD, every year. This ... victims of war, violent crimes and other traumatic events to believe ... deep state of depression. , , Robert Carson ...
    ... , , NASHVILLE, Tenn., ... a leading provider of revenue and payment cycle management ... with the Healthcare Network Accreditation Program (HNAP) from the ... recognizes excellence in health data processing and transactions and ...
    ... to develop PAD if they had constellation of other ... News) -- Women with metabolic syndrome are at high ... dramatically raises the risk of heart disease and stroke. ... taking part in the Women,s Health Study, researchers identified ...
    ... Va., Sept. 9 CRGT, a leading provider of Information ... is a premier sponsor of the Teardrops to Rainbows 7th ... Raspberry Falls Golf & Hunt Club in Leesburg, Virginia. ... Stanford. Teardrops to Rainbows is a non-profit organization that ...
    Cached Medicine News:Health News:FiLife Announces New Twitter Contest on Fixing the American Healthcare System 2Health News:Superfoods for Super Dogs 2Health News:The Aftermath: Robert Carson Krause Writes About his Struggle with PTSD and his Belief that War Is a Senseless Exercise in Futility 2Health News:Emdeon Receives EHNAC Healthcare Network Re-accreditation 2Health News:Emdeon Receives EHNAC Healthcare Network Re-accreditation 3Health News:Metabolic Syndrome May Raise Risk of Peripheral Artery Disease 2Health News:CRGT Sponsors Teardrops to Rainbows Golf Tournament 2
    ... provides rapid reagent dispensing of reagents, buffers ... development. Enables dispensing through eight nozzle manifolds ... with systems for dispensing one, two or ... microplates at volumes from 200 nL to ...
    ... offers an economical, ... alternative to existing ... guarantees accurate and ... the time-consuming recalibration ...
    Multidrop Micro high speed 1 l bulk reagent dispenser rapidly, precisely and accurately dispenses microvolumes of 1-50 l into 384- and 96-well microplates....
    Multidrop DW is a high-speed automated dispenser for Deep Well plates, 1.1 ml test tubes and 96-well plates. Designed for accuracy and precision, the Multidrop DW dispenses up to eight different reag...
    Medicine Products: